SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $635,063,221 |
| Positions | 39 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| UIPATH INC | PATH | CL A | $336,426,500 | 30,950,000 |
| KOLIBRI GLOBAL ENERGY INC | KGEI | COM NEW | $33,845,142 | 6,834,504 |
| AUTOLUS THERAPEUTICS LTD | AUTL | SPON ADS | $15,200,000 | 9,500,000 |
| LYFT INC | LYFT | CL A COM | $14,610,000 | 1,000,000 |
| DEFINIUM THERAPEUTICS INC | DFTX | COM SHS | $13,500,010 | 286,990 |
| WORKIVA INC | WK | COM CL A | $12,127,500 | 250,000 |
| SPRINKLR INC | CXM | CL A | $11,352,000 | 2,200,000 |
| MBX BIOSCIENCES INC | MBX | COM | $11,235,574 | 203,543 |
| ALKAMI TECHNOLOGY INC | ALKT | COM | $10,877,146 | 600,284 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | COM NEW | $10,807,310 | 290,441 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.